Clinical Trial Update: Study of Samalizumab in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of samalizumab in patients with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Samalizumab (samalizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors | Phase 1 | Status: TERMINATED